SonoScape Medical Corp
SZSE:300633
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
25.11
47.47
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
SonoScape Medical Corp
SonoScape Medical Corp
Total Equity
SonoScape Medical Corp
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SonoScape Medical Corp
SZSE:300633
|
Total Equity
¥3.2B
|
CAGR 3-Years
29%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Equity
¥1.9B
|
CAGR 3-Years
61%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Equity
¥12.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
22%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Equity
¥38.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Total Equity
¥3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Equity
¥18.9B
|
CAGR 3-Years
74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SonoScape Medical Corp
Glance View
SonoScape Medical Corp, a company entrenched in the realm of medical technology, weaves its story around innovation and dedication in the healthcare sector. Founded in 2002, this Shenzhen-based company has become a global player in the development and production of medical equipment, particularly in the field of ultrasound and endoscopy. At its core, SonoScape melds cutting-edge technology with practical healthcare applications, aiming to improve diagnostic accuracy and patient outcomes. With its R&D centers rich in technical prowess and creativity, SonoScape continuously pushes forward the boundaries of medical imaging, offering a diverse range of ultrasound systems that cater to various clinical needs and environments. Revenue for SonoScape Medical Corp stems largely from the sale of these high-precision medical devices, which are marketed both domestically within China and internationally. The company thrives on the ever-growing demand for advanced healthcare solutions, ensuring a steady stream of income through its robust distribution channels across numerous countries. In addition to equipment sales, SonoScape provides comprehensive after-sales service packages, ensuring customer satisfaction and fostering long-term relationships with healthcare institutions. By maintaining a strong focus on innovation while meeting industry standards and regulations, SonoScape not only solidifies its financial standing but also enhances its reputation as a significant contributor to the global healthcare landscape.
See Also
What is SonoScape Medical Corp's Total Equity?
Total Equity
3.2B
CNY
Based on the financial report for Sep 30, 2024, SonoScape Medical Corp's Total Equity amounts to 3.2B CNY.
What is SonoScape Medical Corp's Total Equity growth rate?
Total Equity CAGR 5Y
19%
Over the last year, the Total Equity growth was 5%. The average annual Total Equity growth rates for SonoScape Medical Corp have been 29% over the past three years , 19% over the past five years .
You don't have any saved screeners yet